Stable anti-OSMR antibody formulation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11141479
SERIAL NO

16551326

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides, among other things, stable formulations comprising an anti-oncostatin M receptor (OSMR) antibody and having a pH ranging from approximately 6.0-7.6, wherein less than approximately 5% of the anti-OSMR antibody exists as high molecular weight (HMW) species in the formulation.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • KINIKSA PHARMACEUTICALS, LTD.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Holcomb, Ryan Erik Johnstown, US 15 26
Levesque, Philip M Wellesley, US 5 4
Manning, Mark Cornell Johnstown, US 21 34
Nichols, Dave Wellesley, US 17 36
Shahrokh, Zahra Weston, US 61 1378

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Apr 12, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 12, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 12, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00